This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Life Sciences Accounting & Reporting Congress
March 23-25, 2026
Hilton at Penn's LandingPhiladelphia, PA

Neeraj Kumar
Executive Director, General Management and Strategy Finance, Cardiovascular Metabolism and Neuroscience at Novartis
Speaker

Profile

Neeraj Kumar is a senior biopharma finance executive focused on enterprise capital allocation and long-term shareholder value creation. He leads U.S. finance across two major therapeutic portfolios, guiding capital deployment spanning lifecycle management, in-market performance, and business development. His experience spans venture-stage investing, pre-IPO and private equity valuation, corporate divestitures, and large-scale strategic transactions. Neeraj brings a full capital lifecycle perspective, bridging valuation rigor, strategic underwriting, and operating execution. He is a CFA charterholder and holds an MBA from Cornell University.

Agenda Sessions

  • Strategic Capital Deployment in Life Sciences: Investment Frameworks for Financial Leaders in 2026

    4:30pm